Investigation in nephrotic syndrome

Reading File
Finding Sources
Searching PubMed

"nephrotic syndrome" AND "investigations" AND "diagnosis"

Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
I now have all the information needed for a comprehensive answer. Let me compile it.

Investigations in Nephrotic Syndrome

Nephrotic syndrome (NS) is defined by the triad of proteinuria >3.5 g/day, hypoalbuminemia (<3.5 g/dL), and edema - often accompanied by hyperlipidemia and lipiduria. Investigations aim to: (1) confirm the diagnosis, (2) identify the underlying cause, and (3) assess complications.

1. Urine Investigations

Urine Dipstick

  • Detects 3+ or 4+ proteinuria (≥300 mg/dL). Note: dipstick detects only acidic proteins (mainly albumin) and misses light chains (e.g., in myeloma) - these require urine protein electrophoresis (UPEP).

Spot Urine Protein-to-Creatinine Ratio (PCR)

  • Correlates well with 24-hour protein excretion; PCR >2.0 mg/mg (or >200 mg/mmol) indicates nephrotic-range proteinuria.
  • Corrects for urinary dilution/concentration.
  • Nephrotic range in children: protein ≥40 mg/m²/hour or >50 mg/kg/day.

24-Hour Urine Protein

  • The gold standard; >3.5 g/24h in adults confirms nephrotic-range proteinuria.

Urine Microscopy

A critical investigation:
  • Oval fat bodies - sloughed tubular cells containing reabsorbed lipid droplets; show "Maltese cross" pattern under polarized light
  • Fatty casts - cellular casts containing lipid-laden tubular cells
  • Lipid droplets - appear round and clear with a green tinge on light microscopy
  • Lipiduria is the fifth feature of nephrotic syndrome; it is a consequence of proteinuria, not of plasma lipid abnormalities
  • Microscopic hematuria may be present in ~20% of cases (particularly FSGS, membranous nephropathy, or if there is a nephritic component)
  • RBC casts suggest a nephritic overlay

Urine Albumin-to-Creatinine Ratio (ACR)

  • More specific for albumin; important when light chain disease is suspected concurrently.

Urine Protein Electrophoresis (UPEP) + Bence Jones Protein

  • Detects monoclonal light chains or heavy chains in myeloma-associated disease or amyloidosis.
  • Serum free light chain assay may also be used.

2. Blood (Serum) Investigations

Serum Albumin

  • <3.5 g/dL (often <2.5 g/dL in florid NS); confirms hypoalbuminemia.
  • Rapid-onset hypoalbuminemia may produce Muehrcke's lines (horizontal white bands on nails).
  • NS is a hypercatabolic state - proximal tubule catabolism exceeds hepatic albumin synthesis.

Renal Function Tests

  • Serum creatinine, urea/BUN, eGFR.
  • Usually normal or mildly elevated; significant elevation suggests AKI complication or rapidly progressive course.
  • Electrolytes: may show hyponatremia (dilutional).

Lipid Profile

  • Total cholesterol, LDL, triglycerides elevated; HDL reduced.
  • Elevated LDL is driven by increased hepatic lipoprotein synthesis in response to reduced oncotic pressure and altered lipoprotein metabolism.
  • Cholesterol typically >300 mg/dL in florid NS.

Complete Blood Count (CBC)

  • Baseline; may reveal haemoconcentration in underfill state or anaemia.
  • Elevated fibrinogen contributes to hypercoagulability.

Coagulation Studies

  • NS is a hypercoagulable state due to urinary loss of antithrombin III, protein C, protein S, and plasminogen - combined with hyperfibrinogenemia.
  • PT, APTT, fibrinogen; D-dimer if thrombosis suspected.
  • Membranous nephropathy in particular is most strongly associated with renal vein thrombosis (RVT).

Serum Electrophoresis (SPEP)

  • Detects monoclonal paraproteins (myeloma, amyloidosis, LCDD).
  • Complement-protein pattern on SPEP may also suggest secondary causes.

3. Investigations to Determine the Underlying Cause

Complement Studies (C3, C4, CH50)

PatternInterpretation
C3 ↓, C4 ↓, CH50 ↓Classical pathway - SLE nephritis, cryoglobulinemia, MPGN type I
C3 ↓, C4 normal, CH50 ↓Alternative pathway - poststreptococcal GN, endocarditis, shunt nephritis, DDD
C3 normal, C4 normalMCD, FSGS, membranous nephropathy, IgA nephropathy
Complement is normal in uncomplicated primary nephrotic syndrome (MCD, FSGS, primary MN).

Immunological (Serologic) Panel

  • ANA + anti-dsDNA: SLE (lupus nephritis) - also check anti-Sm, anti-C1q
  • ANCA (p-ANCA/c-ANCA): vasculitis-associated GN
  • Anti-GBM antibody: Goodpasture syndrome
  • Anti-PLA2R (anti-phospholipase A2 receptor): found in ~70-80% of primary membranous nephropathy - a non-invasive diagnostic aid, also monitors treatment response and predicts remission
  • Anti-THSD7A antibody: another marker for primary MN (PLA2R-negative cases)
  • Cryoglobulins + Rheumatoid factor: cryoglobulinemia
  • Antistreptolysin O (ASO) / Streptozyme test: poststreptococcal GN

Infectious Serology

  • Hepatitis B surface antigen (HBsAg), anti-HBc: HBV-associated membranous nephropathy
  • Hepatitis C antibody (anti-HCV) + HCV RNA: MPGN, cryoglobulinemia
  • HIV serology: HIVAN (collapsing FSGS)
  • Syphilis (RPR/VDRL/TPHA): membranous nephropathy
  • Blood cultures: infective endocarditis-related GN
  • Malaria serology where endemic

Diabetes Workup

  • HbA1c, fasting glucose: diabetic nephropathy is the most common secondary cause in adults.
  • Long duration, absence of retinopathy/neuropathy, or atypical presentation warrants biopsy.

Thyroid Function Tests (TFTs)

  • Hypothyroidism can present with edema and mimics NS; TFTs baseline.
  • Thyroid-binding globulin is also lost in urine.

Tumour Markers / Cancer Screen

  • Solid tumours (lung, gastric, intestinal, breast, prostate, bladder) may cause paraneoplastic membranous nephropathy.
  • Hodgkin's lymphoma and lymphoproliferative disorders are associated with MCD.
  • Targeted workup based on history and examination.

Serum Free Light Chains + UPEP + Bone Marrow (if indicated)

  • For suspected amyloidosis (AL or AA), myeloma, or light-chain deposition disease (LCDD).

4. Imaging

Renal Ultrasound

  • First-line imaging in all patients with NS.
  • Confirms presence of two kidneys; rules out obstruction or anatomic abnormality.
  • Kidney size is usually normal in primary NS.
  • Large kidneys (>14 cm) are seen in diabetic nephropathy, amyloidosis, HIV nephropathy, or severe acute GN.
  • Small kidneys (<9 cm) with cortical thinning suggest advanced CKD - limits biopsy candidacy.
  • Doppler ultrasound of renal veins if renal vein thrombosis suspected (sudden flank pain, haematuria, worsening proteinuria, especially in membranous nephropathy).

Chest X-Ray

  • Pleural effusions (common in severe NS)
  • Pulmonary oedema

CT / MRI / Venogram

  • CT pulmonary angiogram or renal vein CT/MRI for suspected thromboembolism (RVT, pulmonary embolism) - particularly relevant in membranous nephropathy.

5. Renal Biopsy

The single most important investigation for establishing the histological diagnosis in adults.
PopulationApproach
Adults with idiopathic NSBiopsy required - glomerular pathology cannot be predicted by clinical features alone
Children aged 1-12 yearsPresumptive diagnosis of MCD; treat with steroids without biopsy if typical presentation
Children with atypical featuresBiopsy indicated (microhematuria, hypocomplementemia, reduced GFR, steroid resistance/dependence, age <1 year, macroscopic hematuria, hypertension, extrarenal features)
Adults with positive anti-PLA2RMay support diagnosis of primary MN - biopsy still provides chronicity data

Biopsy Technique Includes Three Modalities:

  1. Light microscopy (LM) - identifies the pattern of glomerular injury
  2. Immunofluorescence (IF) - detects immune complex deposits (IgG, IgA, IgM, C3, C4, C1q, fibrin)
  3. Electron microscopy (EM) - localizes deposits (subepithelial in MN, mesangial in IgAN, subendothelial in MPGN) and identifies foot process effacement (in MCD/FSGS)

6. Summary: Investigations at a Glance

CategoryTestPurpose
UrineDipstick, PCR/ACR, 24h protein, microscopyConfirm nephrotic range proteinuria; lipiduria
BloodAlbumin, creatinine, electrolytes, lipids, CBCConfirm syndrome, assess complications
CoagulationPT, APTT, fibrinogen, AT-IIIHypercoagulable state
ComplementC3, C4, CH50Narrow differential
ImmunologyANA, anti-dsDNA, ANCA, anti-GBM, anti-PLA2RSecondary causes
InfectionsHBV, HCV, HIV, ASLOSecondary causes
MetabolicHbA1c, glucose, TFTsDiabetes, thyroid
ElectrophoresisSPEP, UPEP, free light chainsMyeloma, amyloid
ImagingRenal USSAnatomy, size, obstruction
BiopsyLM + IF + EMDefinitive histological diagnosis

Sources:
  • Comprehensive Clinical Nephrology, 7th Ed. - Laboratory Studies, Imaging & Kidney Biopsy sections
  • Harrison's Principles of Internal Medicine, 22E (2025) - Proteinuric States and Nephrotic Syndrome
  • Brenner & Rector's The Kidney - Nephrotic Syndrome (multiple chapters)
  • ROSEN's Emergency Medicine - Diagnostic Testing in Nephrotic Syndrome
  • Smith & Tanagho's General Urology, 19th Ed. - Essentials of Diagnosis
  • Campbell-Walsh Urology, Nephrotic Syndrome section
This is a shared conversation. Sign in to Orris to start your own chat.